Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 173

The DOI matches its Crossref record.

Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow‐up study on methods

Christensen, Signe Engkjær, Nissen, Peter H., Vestergaard, Peter, Heickendorff, Lene, Brixen, Kim, Mosekilde, Leif · 2008 · Clinical Endocrinology

Abstract

Summary: Background Familial hypocalciuric hypercalcaemia (FHH) must be differentiated from primary hyperparathyroidism (PHPT) because prognosis and treatment differ. In daily practice this discrimination is often based on the renal calcium excretion or the calcium/creatinine clearance ratio (CCCR). However, the diagnostic performance of these variables is poorly documented. Aim To appraise the power of various simple biochemical variables to differentiate between FHH and PHPT using calcium sensing receptor (CASR) gene analysis and histopathological findings as gold standards. Design Follow‐up approach (direct design). Materials We included 54 FHH patients (17 males and 37 females, aged 18–75 years) with clinically significant mutations in the CASR gene and 97 hypercalcaemic patients with histologically verified PHPT (17 males and 80 females, aged 19–86 years). All PHPT patients became normocalcaemic following successful neck exploration. Results Based on receiver operating characteristic (ROC) curve analysis, the CCCR was only marginally better, as judged by the area under curve (AUC = 0·923 ± 0·021 (SE)), than the 24‐h calcium/creatinine excretion ratio (AUC = 0·903 ± 0·027) and the 24‐h calcium excretion (AUC = 0·876 ± 0·029). However, overlap performance analysis disclosed that the CCCR included fewer patients with PHPT together with the FHH patients than the other two variables at different cut‐off points. Based on the ROC curve, the optimal cut‐off point for diagnosing FHH using CCCR was < 0·0115, which yielded a diagnostic specificity of 0·88 and a sensitivity of 0·80. Overlap analysis revealed that a cut‐off point for CCCR at < 0·020 would sample 98% (53/54) of all patients with FHH and include 35% (34/97) of the PHPT patients. Conclusion Our results support the use of the CCCR as an initial screening test for FHH. We suggest a two‐step diagnostic procedure, where the first step is based on the CCCR with a cut‐off at < 0·020, and the second step is CASR gene analysis in patients with FHH or PHPT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2008.03259.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 173

Metadata

Authors
Christensen, S. E., Nissen, P. H., Vestergaard, P., Heickendorff, L., Brixen, K., & Mosekilde, L.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2008-10-14
Volume
69
Issue
5
Pages
713-720
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2119753313
Cited by
173
References
0
FWCI
6.72
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow‐up study on methods. https://app.cochat.ai/papers/10.1111/j.1365-2265.2008.03259.x
The paper
Christensen, S. E., Nissen, P. H., Vestergaard, P., Heickendorff, L., Brixen, K., & Mosekilde, L. (2008). Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow‐up study on methods. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2008.03259.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.